Inventor · disambiguated record
Jean Bennett
Also filed as: BENNETT JEAN
28 granted patents·22 pending applications·405 citations·filing 1989–2024
96Inventor score
Files withUNIV PENNSYLVANIA32ACLAND GREGORY M2ASCIDIAN THERAPEUTICS INC2BENNETT JEAN2BENNETT JR WILLIAM R1
Top patents by PatentIndex Score
50 records- 0192US10266845B2Enhanced AAV-mediated gene transfer for retinal therapiesUNIV PENNSYLVANIA·Filed 2016·Granted Apr 23, 2019·13 cites·9 claims
- 0292US9567376B2Enhanced AAV-mediated gene transfer for retinal therapiesUNIV PENNSYLVANIA·Filed 2014·Granted Feb 14, 2017·48 cites·6 claims
- 0392US8147823B2Method of treating or retarding the development of blindnessACLAND GREGORY M·Filed 2010·Granted Apr 3, 2012·24 cites·8 claims
- 0488US10987433B2Compositions and methods for correction of heritable ocular diseaseUNIV PENNSYLVANIA·Filed 2016·Granted Apr 27, 2021·4 cites·17 claims
- 0586US11197936B2Methods and compositions for treatment of disorders and diseases involving RDH12UNIV PENNSYLVANIA·Filed 2017·Granted Dec 14, 2021·3 cites·17 claims
- 0686US10155794B2Compositions and methods for treatment of disorders related to CEP290UNIV PENNSYLVANIA·Filed 2014·Granted Dec 18, 2018·5 cites·6 claims
- 0785US9433688B2Method of treating or retarding the development of blindnessUNIV PENNSYLVANIA·Filed 2014·Granted Sep 6, 2016·2 cites·17 claims
- 0884US9249425B2Proviral plasmids and production of recombinant adeno-associated virusBENNETT JEAN·Filed 2012·Granted Feb 2, 2016·6 cites·30 claims
- 0983US12442003B2Trans-splicing moleculesASCIDIAN THERAPEUTICS INC·Filed 2024·Granted Oct 14, 2025·0 cites·21 claims
- 1083US10301366B2Compositions and methods for treatment of disorders related to CEP290UNIV PENNSYLVANIA·Filed 2018·Granted May 28, 2019·2 cites·19 claims
- 1182US10392622B2Compositions and methods for self-regulated inducible gene expressionUNIV PENNSYLVANIA·Filed 2015·Granted Aug 27, 2019·4 cites·16 claims
- 1282US9896665B2Proviral plasmids and production of recombinant adeno-associated virusUNIV PENNSYLVANIA·Filed 2015·Granted Feb 20, 2018·2 cites·15 claims
- 1378US11993776B2Trans-splicing moleculesASCIDIAN THERAPEUTICS INC·Filed 2019·Granted May 28, 2024·1 cites·21 claims
- 1478US10668129B2Synergistic combination of neuronal viability factors and uses thereofINST NAT SANTE RECH MED·Filed 2016·Granted Jun 2, 2020·2 cites·5 claims
- 1577US10448823B2Apparatus and methods for testing visual function and functional vision at varying luminance levelsCHILDRENS HOSPITAL PHILADELPHIA·Filed 2017·Granted Oct 22, 2019·4 cites·66 claims
- 1676US11879133B2Gene therapy for ocular disordersUNIV PENNSYLVANIA·Filed 2018·Granted Jan 23, 2024·2 cites·21 claims
- 1774US4967760ADynamic spectral phonocardiographBENNETT JR WILLIAM R·Filed 1989·Granted Nov 6, 1990·126 cites·34 claims
- 1874US2009074723A1Method of Treating or Retarding the Development of BlindnessUNIV PENNSYLVANIA·Filed 2008·Application pending·0 cites
- 1974US2023009257A1Methods and Compositions for Treatment of Disorders and Diseases Involving RDH12UNIV PENNSYLVANIA·Filed 2022·Application pending·0 cites
- 2073US12419973B2Methods and compositions for treatment of disorders and diseases involving RDH12UNIV PENNSYLVANIA·Filed 2022·Granted Sep 23, 2025·0 cites·7 claims
- 2171US5012815ADynamic spectral phonocardiographUNIV YALE·Filed 1990·Granted May 7, 1991·157 cites·12 claims
- 2270US2023037283A9Methods and Compositions for Treatment of Disorders and Diseases Involving RDH12UNIV PENNSYLVANIA·Filed 2021·Application pending·0 cites
- 2369US12403204B2Gene therapy for ocular disordersUNIV PENNSYLVANIA·Filed 2021·Granted Sep 2, 2025·0 cites·10 claims
- 2467US2013216500A1Method of treating or retarding the development of blindnessUNIV PENNSYLVANIA·Filed 2013·Application pending·0 cites
- 2567US2024218394A1Gene therapy for ocular disordersUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 2666US12097267B2Methods and compositions for treatment of ocular disorders and blinding diseasesUNIV PENNSYLVANIA·Filed 2020·Granted Sep 24, 2024·0 cites·9 claims
- 2764US2023233709A1Gene therapy for ocular disordersUNIV PENNSYLVANIA·Filed 2022·Application pending·0 cites
- 2864US2017014529A1Method of Treating or Retarding the Development of BlindnessUNIV PENNSYLVANIA·Filed 2016·Application pending·0 cites
- 2964US2016263246A1Method of Treating or Retarding the Development of BlindnessUNIV PENNSYLVANIA·Filed 2016·Application pending·0 cites
- 3062US2012225930A1Method of treating or retarding the development of blindnessACLAND GREGORY M·Filed 2012·Application pending·0 cites
- 3162US2007077228A1Method of treating or retarding the development of blindnessCORNELL RES FOUNDATION INC·Filed 2006·Application pending·0 cites
- 3260US11090392B2Gene therapy for ocular disordersUNIV PENNSYLVANIA·Filed 2016·Granted Aug 17, 2021·0 cites·9 claims
- 3360US10696983B2Method for transducing cells with primary ciliaBENNETT JEAN·Filed 2008·Granted Jun 30, 2020·0 cites·38 claims
- 3460US2022062437A1Compositions and Methods for Correction of Heritable Ocular DiseaseMITCHELL LLOYD G·Filed 2021·Application pending·0 cites
- 3559US11564996B2Gene therapy for ocular disordersUNIV PENNSYLVANIA·Filed 2018·Granted Jan 31, 2023·0 cites·22 claims
- 3659US2004022766A1Method of treating or retarding the development of blindnessFiled 2002·Application pending·0 cites
- 3758US10857240B2Methods and compositions for treatment of ocular disorders and blinding diseasesUNIV PENNSYLVANIA·Filed 2017·Granted Dec 8, 2020·0 cites·9 claims
- 3855US11827898B2Gene therapy for ocular disordersUNIV PENNSYLVANIA·Filed 2018·Granted Nov 28, 2023·0 cites·14 claims
- 3955US2022204989A1Triple helix terminator for efficient rna trans-splicingUNIV PENNSYLVANIA·Filed 2020·Application pending·0 cites
- 4054US2021115473A1METHOD FOR TRANSDUCING Title of Invention CELLS WITH PRIMARY CILIAUNIV PENNSYLVANIA·Filed 2020·Application pending·0 cites
- 4150US11793887B2Gene therapy for treating peroxisomal disordersUNIV PENNSYLVANIA·Filed 2018·Granted Oct 24, 2023·0 cites·21 claims
- 4249US2022348957A1Adeno-associated viruses and their uses for inner ear therapyTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SVCS·Filed 2021·Application pending·0 cites
- 4348US2015116667A1Apparatus and methods for testing visual function and functional vision at varying luminance levelsPHILADELPHIA CHILDREN HOSPITAL·Filed 2014·Application pending·0 cites
- 4447US2022096658A1Adeno-associated viruses and their uses for inner ear therapyCHIEN WADE W·Filed 2019·Application pending·0 cites
- 4547US2003003582A1Trans-viral vector mediated gene transfer to the retinaTRANZYME INC·Filed 2002·Application pending·0 cites
- 4647US2025176822A1Methods, systems, and computer readable media for assessing visual function using virtual mobility testsUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 4745US2015374851A1Aav vectors expressing sec10 for treating kidney damageUNIV PENNSYLVANIA·Filed 2015·Application pending·0 cites
- 4844US11206977B2Vision test for determining retinal disease progressionUNIV PENNSYLVANIA·Filed 2015·Granted Dec 28, 2021·0 cites·18 claims
- 4944US2012244127A1AAV Vectors Expressing SEC10 for Treating Kidney DamageLIPSCHUTZ JOSHUA H·Filed 2010·Application pending·0 cites
- 5040US2021045628A1Methods, systems, and computer readable media for testing visual function using virtual mobility testsUNIV PENNSYLVANIA·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jean Bennett files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →